Skip to main content

Advertisement

Table 2 Management during hospitalization in tertiary and secondary care hospitals in Estonia in 2001 and 2007

From: Changes in treatment and mortality of acute myocardial infarction in Estonian tertiary and secondary care hospitals in 2001 and 2007

  Tertiary care hospitals   Secondary care hospitals  
  Year 2001 Year 2007 P Year 2001 Year 2007 P
  % %   % %  
  n = 210 n = 327   n = 213 n = 360  
Medications       
   Aspirin 87.1 94.2 0.004 88.3 86.4 0.428
   Clopidogrel/ticlopidine 17.1 61.5 < 0.001 0.0 10.6 NA
   Anticoagulants 89.0 93.0 0.092 85.4 92.8 0.007
   Glycoprotein IIb/IIIa inh 12.4 38.8 < 0.001 0.5 3.1 0.037
   Beta-blockers 79.5 82.6 0.395 76.1 77.8 0.707
   Nitrates 92.4 78.9 < 0.001 96.7 85.6 < 0.001
   ACEI/ARB 70.5 74.9 0.267 37.1 62.2 < 0.001
   Statins 26.7 67.9 < 0.001 5.6 30.8 < 0.001
Cardiac catheterization 35.7 78.3 < 0.001 0.0 6.7 NA
Revascularisation 27.6 64.2 < 0.001 0.0 4.2 NA
   PCI 22.4 61.5 < 0.001 0.0 4.2 NA
   CABG 5.2 3.7 0.381 0.0 0.0 NA
Reperfusion for STEMI 42.3 64.2 < 0.001 44.1 34.1 0.073
   Thrombolysis 35.4 7.4 < 0.001 44.1 34.1 0.073
   Primary PCI 6.9 56.8 < 0.001 0.0 0.0 NA
Echocardiography 81.9 85.3 0.292 52.1 51.9 0.969
Stress-testing 19.0 1.8 < 0.001 8.0 2.6 0.023
  1. ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin II receptor blockers; CABG, coronary artery bypass grafting; NA, not applicable; PCI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction